L&G Pharma Breakthrough UCITS ETF • BIOT
Capital at risk.
About L&G Pharma Breakthrough UCITS ETF
Base currency
Traded currency
ISIN
Trading on
Ticker
Fund manager
Key facts & metrics
Fund size
Income
Expense Ratio
Dividend Yield
Valuation
Price to prospective earnings
Price to book
Price to sales
Price to cashflow
Price
52-week High
52-week Low
50-day moving average
200-day moving average
Technicals
YTD
Year 1
Year 3
Year 5
Year 10
Volatility Year 1
Volatility Year 3
Expected Return Year 3
Sharpe Ratio
Growth
Long term projected earnings
Historical earnings
Sales
Cash flow
Book value
Sector breakdown
Healthcare
%Â 94,24
Materials
%Â 5,76
Regional breakdown
North America
%Â 60,17
Asia
%Â 20,50
Europe
%Â 16,88
UK
%Â 2,45
Top 10 Holdings
Innocare Pharma Ltd
3.8%
Alnylam Pharmaceuticals
3.71%
Pharming Group NV
3.49%
Ionis Pharmaceuticals Inc
3.47%
KemPharm Inc
3.28%
BioCryst Pharmaceuticals Inc
3.17%
Kyowa Kirin Co Ltd
3.14%
LG Chemicals
3.06%
Xeris Pharmaceuticals Inc
3.06%
Royalty Pharma Plc
3.01%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.
Build your future fund today!
Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!
Capital at risk.
FAQs
The name of BIOT is L&G Pharma Breakthrough UCITS ETF.
The primary ticker of L&G Pharma Breakthrough UCITS ETF is BIOT.
The ISIN of L&G Pharma Breakthrough UCITS ETF is IE00BF0H7608.
The total expense ratio (TER) of L&G Pharma Breakthrough UCITS ETF amounts to 49.00% p.a. These costs are withdrawn continuously from the fund assets and already included in the performance of the ETF. You don't have to pay them separately.
Yes, L&G Pharma Breakthrough UCITS ETF does pay dividends.
L&G Pharma Breakthrough UCITS ETF is traded in GBX.
L&G Pharma Breakthrough UCITS ETF is distributing.
The fund manager of L&G Pharma Breakthrough UCITS ETF is Legal & General.
The fund size of L&G Pharma Breakthrough UCITS ETF is £20.9M.